Identification of FABP5 as an immunometabolic marker in human hepatocellular carcinoma.
Liu F, Liu W, Zhou S, Yang C, Tian M, Jia G, Wang H, Zhu B, Feng M, Lu Y, Qiao T, Wang X, Cao W, Wang X, Shi Y, Wu D.
Liu F, et al.
J Immunother Cancer. 2020 Jul;8(2):e000501. doi: 10.1136/jitc-2019-000501.
J Immunother Cancer. 2020.
PMID: 32611686
Free PMC article.